{"ticker": {"uuid": "9040d5b4-e9d0-457c-8da8-d2840d22bee0", "symbol": "BALAXI", "name": "Balaxi Pharmaceuticals Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Balaxi Pharmaceuticals (BALAXI) Q3 2025 earnings summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNSVloTHFPX29hMFdwNkZ6WGRRSWFqZmpHWXNXR2RjcEk0WGFFT1I1WXg1eGU4cU12YUJPLThWbURaQkhabzVVZVRCWVpGeG5NcmV6ZF9BdE01b3dPOVhkYWtrbWVlYmhHUE4zYkZaYzBiRUE1Q254WVBWZW02a3NaNmVqS1VDQUE?oc=5", "source_name": "Quartr", "published_at": "2026-07-13T09:56:51+00:00", "published_display": "13 Jul 2026 09:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi FY26 net profit falls 94% to \u20b91.42 crore", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOWHMwRnRSbEdPdTRhVl9TRHU4R0trUUoyelZmbVc0a3J5MERWcFotWDZTVXhZb0huRUZKV2pRYVVXZElTVFM5Nk5fTFUwaURrUmVzYlNYUFFxRDNjUnJzU0FKbERJbUdzZ2ViUE1ZanI3R0U4dFlKRkhBQWdjdFozNlJqOUpPS2FnSnJleTVlbXh2WUpyb3lRTktoV2xmQlYyaTM2QXZINDVvMTctM1Fz?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Submits RTA Report on Physical Share Transfer Re-Lodgements for April 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQOG90ZUtzMktmTmVQX1lmUXlJUTZ3MHVxUHF3Y2l5TWRQUThXVzlkWW5KYWpsNGtkNk5EUDZDUXB0R0k2Ynk4TEJLQjVWSHFwRTVMWkJRY0w2NGNjQ2JMcm51SUxMS0F2SC0ybl9PREp6MnlNYzg3WDN4VmRPdFJTY3Z3dlBXMGZzeXZKcUpxZENFdXVMc3ZGR0E4UDZFUEl5a01XdE9vWEwxbFNOYmhoUVRycHFxSW9Qd3YtSzFMQml0X0MtdEx4TFp3RkRwb0VpV3V0N3FrTmFnTWFCQ3JEdDc2S1pJTlBNMGc?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Ltd. Share Price Today - Balaxi Pharmaceuticals Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQWFFPYlJCTHBvVVg4VXdGZTBzSFp4UTYwbndBNS1QU1A5dEQ3eVo5ck9vVE5wNEM0NWxuank1QVNGSjBUSmZwdnhwcjZjYW5CRFZJenY4MkVyd2ZVNmQzRnJwc1lvWVk2cUdtc285V0IxZmh0RDNFbkFkNkVLTWF4OXZZYzB1WXA1N2c?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T16:40:53+00:00", "published_display": "03 Jan 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Limited (NSE:BALAXI) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bulk deals: Unico Global Opportunities Fund buys 8.3% stake in Balaxi Pharma, Malabar India picks up 1.15%...", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxQX1ZGZzF3eHZKNkFIVE1lY1A0OWpsUUpFSVRSQ3ZxYXRHSldLclktMXZCRXJwYlNRNjV6andrZkh5eHBRQkhhZlRMeHN0S3l4QWRDSkZGeUlqUmt1dWRMak9fcmV3YmFVQkdEVFBHV25GRkdmd0REQlFzS2FjdWV2NGdMdTJJSEZKOHZFczcxbDJRWW5EUC12Mll6VHVPVlVTU2pZMnp0S0ZtYjg2YzJPQkxoTC1wMkdySzJOVU5VaGNzVzFWek9lOVhpaTB1Ql9fQlI1S1NqVVRLVElNWmFmNkRuTm1zOElnaEFMaEczQjVEdldhZHdwX2UyQUhua2hIRzgw0gGIAkFVX3lxTE9zVlhubVViZnUweXdfaWtFa2xrVkVGTURnWUhvb3M4SWFXMUZFWkFXX3FiMTMybG5RX2NidHE2NTFuck00VTNSZkF3SnVneFl1bmhpQWFFMElNeUJDZXN0NnNFM2lSb2haUFk2Q2VSdVZ3TjJCcmhHYkFGbkEtd3p3Zm1HZzVKLTEzVkdBWi1hak82cXJMVDV3WXRxS3dFVFloaXpZbjJES2oySHpSVzhlM0JyS3BPRWFPRUZ6VVYtcHRMQl9UUXFNaDVoMnFTV1dhTndtV2c2S3BrOXYtcEY3VTgtZHFsNUhJLWhZMUVUQ1JrWmNOcUtwNW9ZejdDcTN0WlFDZDhNdw?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-03-03T08:00:00+00:00", "published_display": "03 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals growth remains robust on back of Geographical Expansions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2023-02-01T08:00:00+00:00", "published_display": "01 Feb 2023 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharma to invest Rs 85 crore in new plant at Jadcherla", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The New Indian Express", "published_at": "2022-12-14T08:00:00+00:00", "published_display": "14 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Indian Pharma Post", "published_at": "2022-12-14T08:00:00+00:00", "published_display": "14 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Limited conducts Groundbreaking Ceremony for its upcoming Rs 85 Cr State-of-the-Art Manufacturing Facility in Hyderabad", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxQaDVpOHVHM0JVcDNPWjNWM01Eb0w4ZDIyZ3hfNHk3OGE0dFZuTXNHcDlkbWZIaEN2NHNoMXhpMERzT1FFTVRiMkxhY1BfVGdqVy1UeTZwOV9vYVBqSjRtMjRudXpCMkUwT25pRTZBN0EtV0d4VzVBd1d6S01qWllkNER1ZklYTjNvVlg5X0dXaGVUX0hjQ0x4RXlPWEhXV2EyMmhyZzhKdE05V0RUWms5aWVzMWxfYUNta1M3d0hPdG1IRjJxb2VzZHN3T25VbURFblM1TzJBREhJTW54N1RrSEE1c3IzVDBtUjhWbnMtTVFYdHBxbnIwdEF3QkVySDlaWHg1N19kbW9Ca0drZ1QxaEcwVWxUNU5rRXfSAZ8CQVVfeXFMUFlPLTdsMDh4N1ZiMkJJQnlydVQ0d1ZWWkhfbjZVV01kNk40ejF2OFFwSzF5SXlEMjlSUmlVQUlDNmI4NWJFa3lLOTU2N0RBR1VNRktPMDhWODJTaURTU3RibVp4MkY2a2c4UkhRblBEb1JGS3pnZGFtb0o2SkIxWlE1QTNmQ2ZMcU5QaEZEcUtuVERDVmZyMmpscnVFN2NPUmtHRHRkaDV2V3kxU2xPOGJ6bXNmVDdyU3diVVB4MDlmVGxyWWlTVi1kMS15czJHYml0MkNfNFMzNmlZeDU0d2U4SlUxZ2s2TnBPM0duWEJiU0o0UExIUzhCbmltajN3a2hKaTlyNU9EZGd1YmozUUpoczhLU0pUYXJjT01NZU0?oc=5", "source_name": "ThePrint", "published_at": "2022-12-13T08:00:00+00:00", "published_display": "13 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharma to issue Rs. 49.61 crore Equity Shares/Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNSVcwNXBncl8tQ1dzaHZLTFJLUUVOMUNuaThuOTVsT3gzZWdTcG1iNmJXclFZX3pZSE1iUlVOY0VrbkM1UTRJNkkwYVJWaHJYeTdkWGYycWE2NGJ4emlpRkN5UUhqMEZvck8teFozZ0tDZDVKZUdOSHo3MUpfZV8wRmFRR3BoSGo1aDV2UGY4aDE3R0R0MzZYa0tFRjQyVTVBOGNvSNIBqwFBVV95cUxQODJvcEhJX2NFdTlzZ1g2OVVid25JZW5zWUFGbWtWMHRiSVZyVTBaLTFEWEQwOXp3QnYyMV9MNFZsLXNqZTJSaUFicWMwdDB0dWJOc3lkN0hEWDJZVlY1MDVqWnloVWFBSEkxa29VZHZpSlVSU1RWeTZQY3dCZWI1NWtweE5BcjNZdUdMc3VQUFIwUmZKSXYxWmRNTkRJU1gtOUEyQkU3SHUxZEE?oc=5", "source_name": "Indian Pharma Post", "published_at": "2022-09-06T07:00:00+00:00", "published_display": "06 Sep 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Ltd. Share Price Today | Balaxi Pharmaceuticals Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPZHFJVlIwU1R4MGlMSG5XYUdBeGtUbG1lOXVocGlTV0d5YTRJUl9aTTZleEdzVnRzUHVrcGp6T1h3TzJHdklyYjhvUzNRSTlMNFVFZ0p5Uk1RclV4SnVWNGhXcVpySUpKbEltbWRzMW0ycnA2bi0xZmVHSEZETHdRdTM4OA?oc=5", "source_name": "Value Research", "published_at": "2022-03-27T21:12:52+00:00", "published_display": "27 Mar 2022 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharma posts PAT of Rs 381 million for FY21", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPSXRJLVlfdS1QdG0yZDFodFFkbmotcEpzSnZVN0ZYVHQtdDN2Mnp3Wm9jaGhhdDIyUWpmbG1SaWFEOTFzLXp2ZFdxOWx2YjJ2NXphRDZKdUtaNHo3dk1GM004ZzlDMVl6NVI0c0MxbHJ3NlhKTWxIb0s5N1FXVzdWVVFKb2pnb2k4cUdPbDdGUTczRE04VnZncDNlQU54OWZ4eWRiZA?oc=5", "source_name": "BioSpectrum India", "published_at": "2021-05-25T07:00:00+00:00", "published_display": "25 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Ventures Limited renamed as Balaxi Pharmaceuticals Limited", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Times of India", "published_at": "2020-10-08T07:00:00+00:00", "published_display": "08 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BALAXI Stock Price and Chart \u2014 NSE:BALAXI", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBvUFFjZmZDQlI5T3dndVo0MXB3NnNvRC13a211SFhUM0Z4eVduUk1tVS1sTEU2QjEtb3g0RXk3WkNxTzRtM3VmclZfZVJrS2tZQmN5bWZUMDBVWE0?oc=5", "source_name": "TradingView", "published_at": "2017-10-12T09:01:45+00:00", "published_display": "12 Oct 2017 09:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Balaxi Pharmaceuticals (BALAXI) Q3 2025 earnings summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNSVloTHFPX29hMFdwNkZ6WGRRSWFqZmpHWXNXR2RjcEk0WGFFT1I1WXg1eGU4cU12YUJPLThWbURaQkhabzVVZVRCWVpGeG5NcmV6ZF9BdE01b3dPOVhkYWtrbWVlYmhHUE4zYkZaYzBiRUE1Q254WVBWZW02a3NaNmVqS1VDQUE?oc=5", "source_name": "Quartr", "published_at": "2026-07-13T09:56:51+00:00", "published_display": "13 Jul 2026 09:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi FY26 net profit falls 94% to \u20b91.42 crore", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOWHMwRnRSbEdPdTRhVl9TRHU4R0trUUoyelZmbVc0a3J5MERWcFotWDZTVXhZb0huRUZKV2pRYVVXZElTVFM5Nk5fTFUwaURrUmVzYlNYUFFxRDNjUnJzU0FKbERJbUdzZ2ViUE1ZanI3R0U4dFlKRkhBQWdjdFozNlJqOUpPS2FnSnJleTVlbXh2WUpyb3lRTktoV2xmQlYyaTM2QXZINDVvMTctM1Fz?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Submits RTA Report on Physical Share Transfer Re-Lodgements for April 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQOG90ZUtzMktmTmVQX1lmUXlJUTZ3MHVxUHF3Y2l5TWRQUThXVzlkWW5KYWpsNGtkNk5EUDZDUXB0R0k2Ynk4TEJLQjVWSHFwRTVMWkJRY0w2NGNjQ2JMcm51SUxMS0F2SC0ybl9PREp6MnlNYzg3WDN4VmRPdFJTY3Z3dlBXMGZzeXZKcUpxZENFdXVMc3ZGR0E4UDZFUEl5a01XdE9vWEwxbFNOYmhoUVRycHFxSW9Qd3YtSzFMQml0X0MtdEx4TFp3RkRwb0VpV3V0N3FrTmFnTWFCQ3JEdDc2S1pJTlBNMGc?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Ltd. Share Price Today - Balaxi Pharmaceuticals Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQWFFPYlJCTHBvVVg4VXdGZTBzSFp4UTYwbndBNS1QU1A5dEQ3eVo5ck9vVE5wNEM0NWxuank1QVNGSjBUSmZwdnhwcjZjYW5CRFZJenY4MkVyd2ZVNmQzRnJwc1lvWVk2cUdtc285V0IxZmh0RDNFbkFkNkVLTWF4OXZZYzB1WXA1N2c?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T16:40:53+00:00", "published_display": "03 Jan 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Limited (NSE:BALAXI) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPSXpjVTNCTHVBT3hQcHpxU0MzYmhCNFVJa3R3MnpKRGRXMElPcjdId3I5ZEgzY0pQTXdJNWhaMUp0azlWSnQxNnd1aGJXbTNGUGY1QXNLYUFwRTVaLUVyN092TzJCT1N4cElzZkh3ZHEwQi1Cbk1kbDBjTnh5SzRRMmxzOGc5MzRxalFSaTVEOUNCMFl0ejhiZnM5YTB2bDBNMWpySm1oNjlVRXZqbkZIa2xUSWZYeGl3bHZTTW5wSDZzdHVwaVNKTGwtZFVqaDdfdjZpdEZfcWFyRnZqVmNOaThSbUNhZ9IB6wFBVV95cUxOOHVEM1ZoUno0MUtVNnZ3dk53WF8xaEt2NURhMkcxTXppWVRIMElLRTdyaFB4QWs5Y1E0XzFEWGJueTlFSmo1eG1OT0VOZWltNlNJcXFCRk1leU9WeFMwalVVMzdtd1FNSjZVbmVTSzFHUlcxQnNBU1diZUxrRFo4b19RTjZNRkE1eEg0Wk5TcjE4SC1SRWRNa1I1WDl4ZHpRNEVXZFAyejU1RHVCcG1jWHZqRDdyWUJuT0xDZFFaOHhCWkR6WGxxVURIajd6NGczRzNmcTFqWlVIOUQxdW41WGFUcFByRXgwU0hV?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNY0pxN2lnWXR1SWFGUlRQd3p6WDc1dHN1YXpqS0pzak1uaTJHRG55c1JFOU1zbjFwb2NFb01pTEYtTkpjUHVTS1NtVXp4dldfS08wVjVyWkVmWlduZnpObHFFNy1tUEsxYzFDNzA0NF9KaS05bkRCd3k3ZXlxT0V6d0YtWExwMk00QklMX212ZUNhU1NPVml3eFlfc3VNcnp0UjRNUm5Hbk5MNi03M2NQR2pFTXBvbnJ3d1FhOVNTbEFiS1hyNDRsQ2t0d3pzbkRWMER6dkNXWWpoOEJrWVHSAeMBQVVfeXFMTk8xWnBZNV9CQkM0Y3E2Nk1FUkxiblV5elppTGJxYy1qSVpGX0NGemxzWUZTMzQySm1YU29hNkUwYUo0RGd3dDN1d1VzLUNsSk5aRGR0ZnREQzRJVGRNYnhhTURyNm9hWmVGZ0JaXzNXenNzYldGWmdKYS0yZUx1OUtCeXdfRmRJckVwTXBnS1QtbU5nSTNNb0ZZQ2JiU3p3M2J0REg3eG95VFV4QmdUbnJ4OEFqN1doM09rdElxaDJSX19hQ3hzTnJkTU03SDk5c2pEVlVvdEFSSi1iMWQ3amtYbkE?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bulk deals: Unico Global Opportunities Fund buys 8.3% stake in Balaxi Pharma, Malabar India picks up 1.15%...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-03-03T08:00:00+00:00", "published_display": "03 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals growth remains robust on back of Geographical Expansions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2023-02-01T08:00:00+00:00", "published_display": "01 Feb 2023 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharma to invest Rs 85 crore in new plant at Jadcherla", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The New Indian Express", "published_at": "2022-12-14T08:00:00+00:00", "published_display": "14 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Indian Pharma Post", "published_at": "2022-12-14T08:00:00+00:00", "published_display": "14 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Limited conducts Groundbreaking Ceremony for its upcoming Rs 85 Cr State-of-the-Art Manufacturing Facility in Hyderabad", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "ThePrint", "published_at": "2022-12-13T08:00:00+00:00", "published_display": "13 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharma to issue Rs. 49.61 crore Equity Shares/Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNSVcwNXBncl8tQ1dzaHZLTFJLUUVOMUNuaThuOTVsT3gzZWdTcG1iNmJXclFZX3pZSE1iUlVOY0VrbkM1UTRJNkkwYVJWaHJYeTdkWGYycWE2NGJ4emlpRkN5UUhqMEZvck8teFozZ0tDZDVKZUdOSHo3MUpfZV8wRmFRR3BoSGo1aDV2UGY4aDE3R0R0MzZYa0tFRjQyVTVBOGNvSNIBqwFBVV95cUxQODJvcEhJX2NFdTlzZ1g2OVVid25JZW5zWUFGbWtWMHRiSVZyVTBaLTFEWEQwOXp3QnYyMV9MNFZsLXNqZTJSaUFicWMwdDB0dWJOc3lkN0hEWDJZVlY1MDVqWnloVWFBSEkxa29VZHZpSlVSU1RWeTZQY3dCZWI1NWtweE5BcjNZdUdMc3VQUFIwUmZKSXYxWmRNTkRJU1gtOUEyQkU3SHUxZEE?oc=5", "source_name": "Indian Pharma Post", "published_at": "2022-09-06T07:00:00+00:00", "published_display": "06 Sep 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharmaceuticals Ltd. Share Price Today | Balaxi Pharmaceuticals Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPZHFJVlIwU1R4MGlMSG5XYUdBeGtUbG1lOXVocGlTV0d5YTRJUl9aTTZleEdzVnRzUHVrcGp6T1h3TzJHdklyYjhvUzNRSTlMNFVFZ0p5Uk1RclV4SnVWNGhXcVpySUpKbEltbWRzMW0ycnA2bi0xZmVHSEZETHdRdTM4OA?oc=5", "source_name": "Value Research", "published_at": "2022-03-27T21:12:52+00:00", "published_display": "27 Mar 2022 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Pharma posts PAT of Rs 381 million for FY21", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPSXRJLVlfdS1QdG0yZDFodFFkbmotcEpzSnZVN0ZYVHQtdDN2Mnp3Wm9jaGhhdDIyUWpmbG1SaWFEOTFzLXp2ZFdxOWx2YjJ2NXphRDZKdUtaNHo3dk1GM004ZzlDMVl6NVI0c0MxbHJ3NlhKTWxIb0s5N1FXVzdWVVFKb2pnb2k4cUdPbDdGUTczRE04VnZncDNlQU54OWZ4eWRiZA?oc=5", "source_name": "BioSpectrum India", "published_at": "2021-05-25T07:00:00+00:00", "published_display": "25 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Balaxi Ventures Limited renamed as Balaxi Pharmaceuticals Limited", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Times of India", "published_at": "2020-10-08T07:00:00+00:00", "published_display": "08 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BALAXI Stock Price and Chart \u2014 NSE:BALAXI", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBvUFFjZmZDQlI5T3dndVo0MXB3NnNvRC13a211SFhUM0Z4eVduUk1tVS1sTEU2QjEtb3g0RXk3WkNxTzRtM3VmclZfZVJrS2tZQmN5bWZUMDBVWE0?oc=5", "source_name": "TradingView", "published_at": "2017-10-12T09:01:45+00:00", "published_display": "12 Oct 2017 09:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 59, "total_relevant": 17, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 16, "score": 51, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 7.85, "count": 13}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 24.17, "latest_week": "2026-07-10", "one_week_move": 2.1, "four_week_move": 5.8, "twelve_week_move": -8.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.342971, "market_dynamics_buy_signal": false, "relative_strength": -22.03871, "fair_value_gap": -65.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 36.8505, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.1% over one week, +5.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "scanx.trade", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Indian Pharma Post", "count": 2}, {"label": "Quartr", "count": 1}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "CNBC TV18", "count": 1}, {"label": "Moneycontrol.com", "count": 1}, {"label": "Business Standard", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Earnings", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.1% over one week, +5.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Balaxi Pharmaceuticals (BALAXI) Q3 2025 earnings summary"}], "updated_at": "2026-07-18T02:29:11.936441+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}